Employer-Paid Nonmedical Costs for Patients With Diabetes and End-Stage Renal Disease
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Employer-Paid Nonmedical Costs for Patients With Diabetes and End-Stage Renal Disease

Filetype[PDF-232.74 KB]


  • English
    • Details Supporting Files You May Also Like

    Details:

    • Alternative Title:
      Prev Chronic Dis
    • Personal Author:
    • Description:
      Introduction

      Disease conditions such as end-stage renal disease (ESRD), which have severe consequences of disability and mortality, can generate substantial costs for large employers providing life insurance and disability insurance benefits. This study is the first to examine such disease-related nonmedical costs for employers and models the following employer-paid costs for ESRD in patients with diabetes: 1) life insurance benefits, 2) disability benefits, and 3) cost of replacing a worker.

      Methods

      We simulated a hypothetical cohort of 10,000 individuals with the age and sex distribution of a typical employee population in the United States. Data sources for the model parameters included the United States Renal Data System and proprietary life insurance and disability insurance claims databases. In addition, we used published information to identify the structures of typical employee benefits programs and annual salary information and to estimate the cost of replacing lost workers.

      Results

      The study estimated that employers may incur life insurance costs of $55,055 per ESRD-related death, disability insurance costs of $31,671 per ESRD-related disability, and worker replacement costs of $27,869 per ESRD-related lost worker. Overall, the total monthly cost per employee with ESRD and diabetes was $5439.

      Conclusion

      Our study finds that, other than the large direct medical costs documented in literature, ESRD onset also results in substantial nonmedical costs for employers. As employers continue to debate changes in the structure of future health plan benefits to reduce health care costs, they should consider potential indirect cost savings of providing affordable access to medical care that prevents or delays disability and mortality in their workers.

    • Subject:
    • Source:
      Prev Chronic Dis. 2006; 3(3).
    • Document Type:
      Journal Article
    • Collection(s):
      Preventing Chronic Disease
    • Main Document Checksum:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov